Quick Answer
AdaptHealth Corp. reported Total Revenue of $3.24 billion for fiscal year 2025.
AdaptHealth Corp. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $3.24B -0.5% |
$3.26B +1.9% |
$3.20B +7.7% |
$2.97B +21.0% |
$2.45B +132.4% |
$1.06B +99.5% |
| Revenue (ASC 606) | $3.24B -0.5% |
$3.26B +1.9% |
$3.20B +7.7% |
$2.97B +21.0% |
$2.45B +132.4% |
$1.06B +99.5% |
| Net Income | -$70.79M -178.3% |
$90.42M +113.3% |
-$678.89M -1079.4% |
$69.32M -55.6% |
$156.18M +196.6% |
-$161.63M -657.4% |
| Diluted EPS | -$0.52 -185.2% |
$0.61 +111.5% |
-$5.31 -1709.1% |
$0.33 -50.7% |
$0.67 +121.8% |
-$3.08 -224.2% |
| Total Assets | $4.32B -3.8% |
$4.49B -0.5% |
$4.51B -13.6% |
$5.22B -0.6% |
$5.25B +689.5% |
$665.00M +21.7% |
| Cash and Equivalents | — | — | — | — | — | — |
| Long-Term Debt | $1.72B -12.7% |
$1.96B -6.2% |
$2.09B -2.7% |
$2.15B -1.4% |
$2.18B +181.2% |
$776.57M +96.5% |
| Stockholders Equity | $1.52B -3.3% |
$1.57B +7.7% |
$1.46B -32.2% |
$2.15B +4.3% |
$2.06B +6315.6% |
-$33.17M -41.6% |
| Operating Income | $90.87M -65.5% |
$263.73M +144.1% |
-$598.40M -414.3% |
$190.41M -15.6% |
$225.60M +216.2% |
$71.35M +142.9% |
| Shares Outstanding | 135.45M +0.6% |
134.60M +1.5% |
132.63M -1.3% |
134.44M +0.4% |
133.84M | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $820.31M | +1.8% | +2.5% |
| Revenue (ASC 606) | September 30, 2025 | $820.31M | +1.8% | +2.5% |
| Net Income | September 30, 2025 | $24.51M | +7.2% | +67.0% |
| Diluted EPS | September 30, 2025 | $0.16 | +6.7% | +60.0% |
| Total Assets | September 30, 2025 | $4.38B | -1.9% | +0.8% |
| Cash and Equivalents | March 31, 2019 | $744.8K | -30.4% | -21.4% |
| Long-Term Debt | September 30, 2025 | $1.74B | -13.4% | -2.7% |
| Stockholders Equity | September 30, 2025 | $1.62B | +6.6% | +1.8% |
| Operating Income | September 30, 2025 | $61.73M | -2.8% | -22.1% |
| Shares Outstanding | September 30, 2025 | 135.42M | +0.7% | +0.2% |
- AdaptHealth Corp. reported Total Revenue of $3.24 billion for fiscal year 2025.
- AdaptHealth Corp. showed a decrease of -0.5% in Total Revenue compared to the prior fiscal year.
- AdaptHealth Corp. reported Revenue (ASC 606) of $3.24 billion for fiscal year 2025.
- AdaptHealth Corp. showed a decrease of -0.5% in Revenue (ASC 606) compared to the prior fiscal year.
- AdaptHealth Corp. reported Net Income of -$70.79 million for fiscal year 2025.
- AdaptHealth Corp. showed a decrease of -178.3% in Net Income compared to the prior fiscal year.
- AdaptHealth Corp. reported Diluted EPS of $0.52 per share (loss) for fiscal year 2025.
- AdaptHealth Corp. showed a decrease of -185.2% in Diluted EPS compared to the prior fiscal year.
- AdaptHealth Corp. reported Total Assets of $4.32 billion for fiscal year 2025.
- AdaptHealth Corp. showed a decrease of -3.8% in Total Assets compared to the prior fiscal year.
- AdaptHealth Corp. reported Cash and Equivalents of $947.1 thousand for fiscal year 2018.
- AdaptHealth Corp. showed an increase of +690.4% in Cash and Equivalents compared to the prior fiscal year.
- AdaptHealth Corp. reported Long-Term Debt of $1.72 billion for fiscal year 2025.
- AdaptHealth Corp. showed a decrease of -12.7% in Long-Term Debt compared to the prior fiscal year.
- AdaptHealth Corp. reported Stockholders Equity of $1.52 billion for fiscal year 2025.
- AdaptHealth Corp. showed a decrease of -3.3% in Stockholders Equity compared to the prior fiscal year.
- AdaptHealth Corp. reported Operating Income of $90.87 million for fiscal year 2025.
- AdaptHealth Corp. showed a decrease of -65.5% in Operating Income compared to the prior fiscal year.
- AdaptHealth Corp. reported Shares Outstanding of 135.45 million shares for fiscal year 2025.
- AdaptHealth Corp. showed an increase of +0.6% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: